Cornelis
Daniel Cornelis, Melsen-Merelbeke BE
Patent application number | Description | Published |
---|---|---|
20160081253 | Spathiphyllum plant named 'SP6531' - A new and distinct | 03-17-2016 |
Dawn M. Cornelis, Corona, CA US
Patent application number | Description | Published |
---|---|---|
20150127370 | System and Method for Identifying and Correcting Billing Errors in High-Volume Billing and Claim Adjudicating Systems - A system and method identifies coding errors in claims for an episode of medical care, comprising in combination a process that translates into one format, input claims data that encode multiple health care services delivered in an episode of care for a patient; a process that pre-sorts the claim data by excluding claim data that is incorrect, incomplete, duplicated, and improperly formatted; a compiling process for gathering claims data for the episode of care; and a coding conflict engine for comparing the data in each claim of the episode of care with the data in all other claims in the episode of care to determine inconsistencies in the record. The results may be processed to decide how to recover incorrect payments. | 05-07-2015 |
Hamelink Cornelis, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20100218704 | MODIFIED SULPHUR AND PRODUCT COMPRISING MODIFIED SULPHUR AS BINDER - The invention provides modified sulphur comprising sulphur and a polysulphide-containing organosilane in an amount of in the range of from 0.3 to 25 wt % based on the weight of sulphur, in which modified sulphur the combined amount of sulphur and polysulphide-containing organosilane make up in the range of from 90 to 100 wt % of the obtained modified sulphur and wherein the polysulphide-containing organosilane is of the general molecular formula (1): (X | 09-02-2010 |
Lucas Johannes Cornelis, Maastricht NL
Patent application number | Description | Published |
---|---|---|
20090305945 | NOVEL NUTRACEUTICAL COMPOSITIONS - The present invention describes a composition which comprises a protein hydrolysate or a protein hydrolysate and one amino acid hydrolysate for the long term treatment or prevention of type 2 diabetes or pre-diabetes or metabolic syndrome or obesity. | 12-10-2009 |
Marc Cornelis, Gent BE
Patent application number | Description | Published |
---|---|---|
20110226450 | APPARATUS AND METHOD FOR A NATURAL DRAFT AIR COOLED CONDENSER COOLING TOWER - The present invention relates to a natural draft cooling tower that employs an air cooled condenser. The aforementioned cooling tower operates by natural draft and achieves the exchange of heat between two fluids such as atmospheric air, ordinarily, and another fluid which is usually steam. The aforementioned cooling tower utilizes a central steam duct riser supplying steam to perimeter ducting via radial ducting. | 09-22-2011 |
20120103570 | Natural Draft Condenser - A system for condensing steam includes a steam supply duct, a supply riser, a supply manifold, a pair of condensing panels, a return manifold, and a condensate return. The steam supply duct is configured to convey steam from a steam generator. The supply riser is configured to convey steam from the steam supply duct. The supply manifold is configured to convey steam from the supply riser. The pair of condensing panels is configured to receive steam from the supply manifold. The supply manifold bifurcates with each bifurcation being configured to supply a respective condensing panel of the pair of condensing panels. The return manifold is configured to receive condensate from the pair of condensing panels. The condensate return duct is configured to convey condensate from the return manifold to the steam generator. | 05-03-2012 |
Pieter Cornelis, Delft NL
Patent application number | Description | Published |
---|---|---|
20110292391 | COMBINATION OF READER AND INCUBATOR - A detection arrangement for detecting presence of an analyte in a sample includes a processor, a memory, a display, a color measuring device, and a temperature controller for maintaining a constant temperature or a temperature profile of the sample. A method is also provided for determining the presence or absence of an analyte in a fluid by analysis of image data from an assay that generates an image result on an assay medium | 12-01-2011 |
Sigrid Cornelis, St. Martens-Latem BE
Patent application number | Description | Published |
---|---|---|
20100104568 | AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS - The present invention relates to amino acid sequences that are directed against RANK-L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes. | 04-29-2010 |
20110002929 | AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS - The present invention relates to amino acid sequences that are directed against RANK-L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes. | 01-06-2011 |
20130018175 | SINGLE VARIABLE DOMAIN ANTIBODIES AGAINST OX40L, CONSTRUCTS AND THERAPEUTIC USE - The present invention relates to immunoglobulin single variable domain sequences that are directed against (as de-fined herein) OX40L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such immunoglobulin single variable domain sequences. In particular these immunoglobulin single variable domain sequences can block binding of OX40L to OX40. The immunoglobulin single variable domains, compounds and constructs can be used for prophylactic, therapeutic or diagnostic purposes, such as for the treatment of inflammatory disease and/or disorder such as e.g. asthma, allergic asthma, chronic colitis, Crohn's disease, inflammatory bowel disease, and/or arthrosclerosis. | 01-17-2013 |
Sigrid Cornelis, Sint Martens Latem BE
Patent application number | Description | Published |
---|---|---|
20140205601 | AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS - The present invention relates to amino acid sequences that are directed against RANK-L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes. | 07-24-2014 |
20150218281 | SINGLE VARIABLE DOMAIN ANTIBODIES AGAINST OX40L, CONSTRUCTS AND THERAPEUTIC USE - The present invention relates to immunoglobulin single variable domain sequences that are directed against (as defined herein) OX40L, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such immunoglobulin single variable domain sequences. In particular these immunoglobulin single variable domain sequences can block binding of OX40L to OX40. | 08-06-2015 |
Sigrid Godelieve Victor Cornelis, Sint-Martens-Latem BE
Patent application number | Description | Published |
---|---|---|
20130136748 | BIOLOGICAL MATERIALS RELATED TO HER3 - The present disclosure relates to amino acid sequences that are directed against (as defined herein) HER3, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences (also referred to herein as “amino acid sequences of the invention”, “compounds of the invention”, and “polypeptides of the invention”, respectively). The disclosure also relates to nucleic acids encoding such amino acid sequences and polypeptides (also referred to herein as “nucleic acids of the invention” or “nucleotide sequences of the invention”); to methods for 10 preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic purposes, such as the prophylactic, therapeutic or diagnostic purposes mentioned herein. | 05-30-2013 |
Snip Onno Cornelis, Rijswijk NL
Patent application number | Description | Published |
---|---|---|
20090311371 | CONTINUOUS METHOD FOR THE PRODUCTION OF A YEAST FERMENTED BEVERAGE - The present invention provides a continuous method for the production of a yeast fermented beverage, comprising the following consecutive continuous processing steps: a. mashing starch-containing and optionally malted raw materials with aqueous liquid; b. heating the mash and enzymatically hydrolysing the starch to fermentable sugars; c. removing spent grain from the heated mash to produce a mash extract, d. converting the mash extract into wort; e. removing organic volatiles from the hot wort; f. diluting the wort with additional water; g. feeding the diluted wort into a propagation vessel in which it is combined with a recirculated stream of yeast-containing residue and in which oxygen is supplied to initiate yeast growth; h. feeding the wort from the propagation vessel into a sequence of one or more fermentation vessels in which the yeast is kept suspended; i. feeding the fermented wort into one or more separators to remove a yeast-containing residue; j. recirculating part of the yeast-containing residue to the propagation vessel; and k. feeding the remainder of the fermented wort to subsequent processing steps; wherein the gravity of the mash extract is maintained at more than 22° P; the gravity of the wort is maintained at more than 22° P until said wort is diluted with additional water; and the gravity of the diluted wort is within the range of 10-35° P; and wherein less than 30 wt. % of the fermentable sugars in the mash extract and wort are derived from fermentable sugars added after hydrolysis of the starch contained in the mash. The present method offers the advantage that it is highly efficient in terms of energy consumption and extraction yields. Furthermore, it achieves extremely high productivity, especially in the operation of the brewhouse. | 12-17-2009 |
Sylvia Cornelis, Hofstade BE
Patent application number | Description | Published |
---|---|---|
20100104469 | METHOD OF REDUCING MALODORS - A method of reducing the formation of malodors in a confined space. More specifically, it is provided a method of reducing the formation of malodors in a confined space, comprising the step of placing a moisture-permeable, water-insoluble sachet comprising a solid composition comprising a hypohalite bleach and/or a peroxygen bleach in close proximity of a source of humidity present within said confined space. | 04-29-2010 |
20100104526 | DEODORIZING SYSTEM - A deodorizing system capable of reducing malodors in confined spaces such as bathrooms, kitchens, cars and cellars. More specifically, it is provided a kit comprising a moisture-permeable, water-impervious sachet and a perfume composition, wherein said sachet comprises a solid composition comprising a hypohalite bleach and/or a peroxygen bleach. | 04-29-2010 |